Skip to main content

Mendelsohn Aaron's Form 4 filing

Vivani Medical, Inc.VANI · filed Dec 31, 2025

Accession no.
0001753926-25-002003
Filed
Dec 31, 2025
Trade date
Jul 8, 2024-Dec 29, 2025
Filing delay
541 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market purchases total $24.6K. It was filed 541 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mendelsohn AaronCIK 0001625195Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 8, 2024Common StockGGiftDisposed−20,000$0.00$0168,170Direct
Dec 29, 2025Common StockPPurchaseAcquired+20,000$1.23F3+$24,600188,170Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)